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Background: Surfactant protein A (SP-A), encoded by two functional genes, SP-A1 and SP-A2, is essential for the
inflammatory process and host defence in the lungs. Recent studies have demonstrated the extrapulmonary
expression of SP-A. Similar to the lungs, the kidneys are organs exposed to external pathogens. The present study
evaluated the expression and location of SP-A in the kidneys. The effect of lipopolysaccharide (LPS) on the
expression of SP-A subtypes was also studied in renal tubular epithelial (HK-2) cells.
Methods: Immunohistochemical staining was performed using polyclonal antibody against SP-A. RT-PCR was also
performed using mRNA from normal human renal tissues and HK-2 cells. The expressions of the SP-A1 and SP-A2
genes were determined by PCR-based RFLP analysis, gene-specific amplification, and direct sequencing of RT-PCR
products. Western blot was conducted to analyse the SP-A protein. HK-2 cells were treated with LPS at various
concentrations (0, 0.1, 1, 2, 5, and 10 μg/mL) for 8 h and at 5 μg/mL at various time points (0, 2, 4, 8, 16, and 24 h).
The LPS-induced expressions of SP-A1 and SP-A2 mRNA and protein were analysed by RT-PCR and Western blot.
Results: SP-A was localised in the renal tubular epithelial cells in the proximal and distal convoluted tubules. SP-A1
and SP-A2 mRNA and protein were expressed in HK-2 cells and human renal tissues, which were significantly
increased in time- and dose-dependent manners after LPS treatment (P < 0.05).
Conclusions: Human renal tubular epithelial cells can express both SP-A1 and SP-A2 genes, which may play
important roles in the inflammatory modulation of the kidney.
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Inflammatory modulationBackground
Pulmonary surfactant, a complex mixture of lipids and
proteins, is produced and secreted by alveolar type II
cells [1]. Approximately 10% of the surfactant is formed
by proteins, which contain the hydrophilic surfactant
proteins A and D (SP-A and SP-D, respectively) as well
as the hydrophobic surfactant proteins B and C (SP-B
and SP-C, respectively) [2]. Human SP-A genes are
located on chromosome 10q22-q23 [3]. Two functional
genes, SP-A1 and SP-A2, which share 96% and 97%* Correspondence: ghxding@gmail.com
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reproduction in any medium, provided the orsimilarities in amino acid and nucleotide sequences, re-
spectively, encode SP-A [4,5]. SP-A also has characteris-
tic structures similar to those of the C-type lectin
superfamily, which forms a flower bouquet structure
composed of six trimeric subunits, each of which con-
sists of 26 kDa to 35 kDa monomers [1,6]. Alveolar type
II and Clara cells in the lungs are the primary cells that
secrete SP-A, which plays a role in preventing the pul-
monary alveoli from collapsing after expiration [7]. The
expression of SP-A, which is not restricted to the respira-
tory system, was also detected in gastric, intestinal [8],
vaginal [9], skin [10], middle ear [11], and Eustachian
tube [12] epithelia. Similar to the lungs, the kidneys are
derived from the endoderm and are exposed to external. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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where SP-A can be expressed.
SP-A participates in the pathophysiological and
physiological regulation of the inflammatory process in
the lungs [13]. SP-A can bind to several bacterial, viral,
and fungal pathogens, thereby resulting in growth inhib-
ition and opsonisation of these pathogens [14]. SP-A
knockout mice were reported to exhibit increased levels
of proinflammatory cytokines and decreased ability of
phagocytosis by alveolar macrophages [15]. George et al.
[16] reported that the complete SP-A gene expression in
the lungs is increased after repeated exposure to an
inhaled endotoxin. Lipopolysaccharide (LPS), a major
component of the outer membrane of Gram-negative
bacteria, induces various inflammatory mediators, in-
cluding tumour necrosis factor, interleukin-1, and
interferon [17]. A recent study has also shown that
LPS selectively induces SP-A gene expression possibly
through TLR2-mediated activation of c-Jun in human
alveolar epithelial A549 cells [18]. However, the effect
of LPS on the regulation of SP-A expression in human
tubular epithelial-like HK-2 cells is not well known.
In the present study, we determined whether SP-A1
and SP-A2 mRNA and proteins are expressed in human
renal tissues and HK-2 cells. We also evaluated the
effects of LPS on the regulation of SP-A subtype expres-
sions in HK-2 cells.
Materials and methods
Materials
Human renal tissue samples obtained from 10 patients
(six males and four females, 58 ± 12 years old) who
underwent operations for renal cancer were used in the
present study. Furthermore, lung tissue samples were
obtained from five patients who underwent operations
for lung cancer (two females and three males, 62 ± 5
years old). The experimental procedure was carried out
according to the protocol approved by the Human Ethics
Committee of the Renmin Hospital of Wuhan University
in China.
Cell cultures
Renal tubular epithelial cells (HK-2, a proximal tubular
cell line derived from normal kidney; purchased from
ATCC, CRL-2190) were cultured at 37°C in a humidified
atmosphere of 5% CO2 and then treated with Dulbecco’s
modified Eagle’s medium (DMEM, Hyclone Pierce, USA)
in a mixture of 10% foetal bovine serum (Invitrogen,
USA) and 1% ampicillin. The culture medium was chan-
ged every 2 d until the cells reached 70% to 80% con-
fluency, at which point they were dissociated with 0.25%
trypsin/EDTA. Subsequently, the cells were incubated for
24 and 72 h to determine mRNA and protein expres-
sions, respectively.Immunohistochemical experiment
Human renal tissues were embedded in paraffin (4 μm
thick) and then immunohistochemically examined using
a SP-A polyclonal antibody (supported by Prof. Guirong
Wang [19]). After the tissue sections were washed and
incubated with 5% H2O2 in methanol for 30 min at
room temperature to inhibit endogenous peroxidase ac-
tivity, they were incubated with a primary antibody
(rabbit anti-human polyclonal SP-A at a dilution of
1:150) at 4°C overnight. The sections were washed in
phosphate-buffered saline (PBS) repeatedly and then
incubated with an anti-rabbit secondary antibody conju-
gated with horseradish peroxidase. Negative controls
were stained with PBS instead of the primary antibody.
Slides were rinsed in PBS and then incubated in diami-
nobenzidine chromogen (Solarbio, China). Colour devel-
opment was observed under a microscope. The slides
were counterstained with haematoxylin to determine the
presence of nuclei.
RT-PCR
Normal human renal tissues and cultured HK-2 cells
were used for RT-PCR analysis of SP-A and GADPH
mRNA, and alveolar tissues were used as positive con-
trols. An oligonucleotide dT primer and primer pairs of
the target and control genes, respectively, for RT-PCR
were purchased from Invitrogen Corporation (Table 1).
Total RNA was extracted from each sample with Trizol
(Invitrogen, USA) following the manufacturer’s instruc-
tions. Total RNA (1 μg) extracted from the tissue was
used for the RT reaction (Takara, China), and then 1 μL
of cDNA was used for amplification at a final volume of
20 μL according to the supplier’s protocol (Fermentas,
Germany). Each PCR product (6 μL) was subjected to
electrophoresis on 2% agarose gel.
Detection of the gene expressions of SP-A1 and SP-A2
mRNA
Approximately 10 μL of the PCR product (a primer pair
common to SP-A1 and SP-A2, 439 bp) was digested
using 2 μL of the restriction enzyme Apa I (Toyobo,
Japan), 2 μL of 10× buffer B, and 18 μL of double-
distilled water at 37°C for 12 h. The treated PCR product
(8 μL) was then electrophoresed on 2% agarose gel.
Another PCR product (a primer pair common to
SP-A1 and SP-A2; 295 bp) was subjected to electrophoresis
on 2% agarose gel and then purified using a TIANgel Midi
purification kit (TianGen, China) according to the manu-
facturer’s instructions. Sequencing was then directly per-
formed using an ABI 3730xl 96-capillary DNA analyser.
Western blot
Proteins from human tissues (kidneys and lungs) and
HK-2 cells were extracted using RIPA lysate [150 mM
Table 1 Primers used for amplification of SP-A1, SP-A2 and SP-A
Target Genes Primer Sequences Tm(°C) Cycles Length(bp)
SP-A F-GAAGGACGTTTGTGTTGGAA 56.1 35 439
commom to SP-A1 and A2 R-TGGATTCCTTGGGACAGCAA
SP-A F-CACTTTTGATGCCATTCAGGAG 56.3 35 295
commom to SP-A1 and A2 R- GGTCAGTCGGGAGTACAGGC
SP-A1 F-TGGGCAAGGTAATCAGTG 49.1 33 365
R-GTCCAGGAAGATGGGTTT
SP-A2 F-TATTGACCGAGCACATACC 49.3 33 212
R-GTCCAGGAAGATGGGTTT
GADPH F-TCCCTGGAGAAGAGCTACGA 53.5 30 200
R-TCGTCATACTCCTGCTTGCT
Liu et al. Journal of Inflammation 2013, 10:2 Page 3 of 8
http://www.journal-inflammation.com/content/10/1/2sodium chloride, 1.0% Triton X-100, 0.5% sodium
deoxycholate, 0.1% sodium dodecyl sulphate (SDS),
and 50 mM Tris at pH 8.0]. The total protein concen-
trations were determined using the bicinchoninic acid
protein assay (Hyclone Pierce). Total protein (50 μg)
was resolved by reducing 12% SDS-polyacrylamide gel
electrophoresis and then transferred electrophoretically
at 60 mA onto nitrocellulose membranes at 4°C over-
night (Bio-Rad, USA). After the samples were blocked
in 5% non-fat milk in Tris-buffered saline, immuno-
blotting was detected using a primary antibody against
SP-A(rabbit anti-human polyclonal SP-A at a dilution
of 1:150) and a anti-rabbit secondary antibody conju-
gated with horseradish peroxidase. Cellular β-actin
protein was immunodetected using a human mono-
clonal antibody against human β-actin (Sigma) as the
internal standard. Immunoproducts were detected
using enhanced chemiluminescence peroxidase detec-
tion reagents (Amersham, Sweden).
LPS-induced expressions of SP-A1 and SP-A2 mRNA and
protein in HK-2 cells
HK-2 cells were incubated with various concentrations
(0, 0.1, 1, 2, 5, and 10 μg/mL) of LPS from Escherichia
coli 0111:B4 (Sigma) for 8 h and then with 5 μg/mL of
LPS at different time points (0, 2, 4, 8, 16, and 24 h). The
cells were collected to detect the expressions of SP-A1
and SP-A2 mRNA and SP-A protein as described above.
Statistics
Data were expressed as mean ± SEM. Results were ana-
lysed using one-way ANOVA with SPSS 13.0 software.
P < 0.05 was considered to indicate statistical significance.
Results
Localisation of SP-A in renal tissue
The immunohistochemical experiment using a spe-
cific SP-A antibody revealed the localisation of SP-A
in the paraffin sections of renal tissues (n = 10). SP-A(Figure 1A) was found in the renal tubular epithelial
cells of the proximal and distal convoluted tubules.
No significant positive staining was found in the con-
trol sections incubated with PBS in place of the pri-
mary antibody (Figure 1B).
Expression of SP-A mRNA in human renal tissues and
HK-2 cells
SP-A-specific cDNA products (a primer pair commom
to SP-A1 and SP-A2, 439 bp) were amplified from the
renal tissues and HK-2 cells (Figure 2). The sizes of the
segment from the renal tissues and HK-2 cells were
similar to those from the lungs. However, the band dens-
ities were reduced in the renal tissues and HK-2 cells.
These findings indicated that the HK-2 cells can tran-
scribe the SP-A genes. The restriction site of the Apa I
restriction enzyme only exists in the SP-A1 gene
(CTGGGCCC) [5,20]. In the Apa I digestion experiment,
the SP-A-specific cDNA segment (a mixture of SP-A1
and SP-A2 cDNA, 439 bp) was digested by Apa I and
then subjected to electrophoresis. Electrophoresis of the
digested SP-A cDNA of the renal tissues and HK-2 cells
revealed two bands at 439 bp and approximately 220 bp.
The result was similar to that in the digested SP-A
cDNA of alveolar tissues (Figure 3). We performed the
Apa I digestion experiment in each sample obtained
from 10 patients. All the samples exhibited similar find-
ings without significant differences.
Another SP-A-specific cDNA product (another pri-
mer pair common to SP-A1 and SP-A2, 295 bp) was
analysed through direct sequencing to identify whether
SP-A is transcribed from one or both SP-A genes in
the HK-2 cells. The sequencing results in Figure 4 show
that the 121st and 163rd base sites have two peaks.
Each of the two base sites was simultaneously found in
two nucleotides (T121G and T163G). Sequence com-
parison showed that identical transcripts (both SP-A1
and SP-A2) were found in the HK-2 cells and the lungs.
We also used the primer pairs specific to SP-A1 or SP-A2.
CB
A
Figure 1 Immunohistochemical detection of surfactant protein
A (SP-A) in renal tissues. (A) A positive stain was observed in the
renal tubular epithelial cells of the proximal and distal convoluted
tubules. A polyclonal antibody against human SP-A was used at a
dilution of 1:150. (B) Negative control sections from human renal
tissues, in which phosphate-buffered saline was used instead of the
primary antibody. (C) Alveolar tissues were used as positive controls.
A positive stain was observed in alveolar type II cells. Arrows in the
figure point at positive staining for SP-A.
SP-A (439 bp)
GADPH (200 bp)
M 1 2 3
Figure 2 RT-PCR analysis of the surfactant protein A (SP-A)
gene in human tissues. SP-A and GADPH transcripts were
amplified by RT-PCR with gene-specific primer pairs. The products
were analysed by 2% agarose gel electrophoresis. Human renal
tissues (Lane 2) and HK-2 cells (Lane 3) showed a clear band of SP-A
cDNA. PCR amplification products of the lungs were used as positive
controls (Lane 1). GAPDH control product was also used (200 bp).
SP-A (439 bp)
Apa I (217/222 bp)
M A P A P A P
1 2 3 4 5 6
Figure 3 Surfactant protein A (SP-A) cDNA segments (a mixture
of SP-A1 and SP-A2, 439 bp) from renal tissues, HK-2 cells, and
the control alveolar tissues were digested by Apa I. A, SP-A
cDNA segments treated with Apa I; P, SP-A cDNA segments
untreated with Apa I. SP-A cDNA segments from renal tissues (Lanes
1 and 2) and HK-2 cells (Lanes 3 and 4). SP-A cDNA segments from
alveolar tissues were used as positive controls (Lanes 5 and 6).
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renal tissues and HK-2 cells were the same as those from
the positive control alveolar tissues (Figure 5).
SP-A immunodetection
Western blot analysis of human renal tissues and
HK-2 cells showed bands at approximately 33 kDa.The expression levels of SP-A were decreased compared
with those in the lungs, as illustrated in Figure 6, in which
one out of the 10 samples is shown. As in the HK-2 cells,
the experiments were repeated several times.
LPS-induced expressions of SP-A1 and SP-A2 mRNA and
protein in HK-2 cells
The effects of LPS on SP-A1 and SP-A2 mRNA and
protein syntheses were determined by RT-PCR and
western blot analysis. In the untreated cells, the expres-
sions of SP-A1 and SP-A2 mRNA and protein were
detected (Figure 7). The HK-2 cells exposed to 1, 2, 5,
and 10 μg/mL of LPS for 8 h had significantly increased
SP-A1 and SP-A2 mRNA and SP-A protein syntheses
compared with those exposed to 0 and 0.1 μg/mL of
LPS (P < 0.05). The LPS-induced (5 μg/mL) expressions
of SP-A1 and SP-A2 mRNA and protein were signifi-
cantly increased within 2 h (P < 0.05) and maintained
beyond 24 h (Figure 8). LPS was found to induce SP-
A1 and SP-A2 mRNA and protein syntheses in time-
and concentration-dependent manners.
SP-A (295 bp)






Figure 4 Sequence data of surfactant protein A (SP-A) cDNA segments (a mixture of SP-A1 and SP-A2, 295 bp). (A) Gel electrophoresis
of SP-A cDNA. Human renal tissues (Lanes 2 and 5) and HK-2 cells (Lanes 3 and 6) showed clear bands of SP-A cDNA. Alveolar tissues were used
as positive controls (Lanes 1 and 4). (B) DNA sequence. Arrows indicate the nucleotides that differ in SP-A1 and SP-A2 gene sequences. The
sequencing result of SP-A cDNA in HK-2 cells revealed the same nucleotide sequence as in alveolar tissue.
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The present study demonstrated the expression and lo-
calisation of SP-A within the renal tissue. LPS selectively
induced the expressions of SP-A1 and SP-A2 mRNA
and protein in human tubular epithelial-like HK-2 cells
in time- and dose-dependent manners.
Although the bands for SP-A (33 kDa) in the kidney
extracts were detected by Kankavi [21], SP-A mRNA
was never detected in the renal tissues of mice [22,23]
and humans. The current study presented the exact
expressions of SP-A mRNA and protein in human renal
tissues. The different results of the present and previous
studies may be attributed to the following. First, the
present study performed repetitive experiments and col-
lected more samples than previous studies. Second,
compared with previous studies, the present study con-
sidered different sites of specimen collection in the renal
tissues, where SP-A had a higher level of expression.M 1 2 3 4 5 6
SP-A1 (365 bp)
SP-A2 (212 bp)
Figure 5 Specific primer extension analysis for SP-A1 or SP-A2
mRNA transcripts. SP-A1 (Lane 3) and SP-A2 (Lane 4) mRNA
transcripts were detected in human renal tissues. SP-A1 (Lane 5) and
SP-A2 (Lane 6) mRNA transcripts were detected in the cultured HK-2
cells. Alveolar tissues were used as positive controls (Lanes 1 and 2).
Both SP-A1 and SP-A2 mRNA transcripts were expressed by human
renal tissues and cultured HK-2 cells.Third, the nucleotide sequence of SP-A in PUBMED has
been revised.
Both SP-A1 and SP-A2 transcripts are expressed in
adult human alveolar type II cells [24]. McCormick et al.
[24] reported that 65% of the SP-A mRNA is encoded by
the SP-A2 gene, whereas only 35% is derived from the
SP-A1 gene in the lungs. The SP-A1 and SP-A2 genes are
differentially expressed in different tissues. Only the SP-A2
gene is predominantly detected in the trachea [25] and
submucosal gland cells in the airway [20], whereas SP-A1
and SP-A2 transcript expressions are both detected in the
small and large intestines of humans [26]. If the SP-A1
gene is only expressed, then the SP-A cDNA fragment
(439 bp) can be digested by Apa I. In this study, the PCR
products (439 bp) of the renal tissues and HK-2 cells were
digested to 217 and 222 bp bands (bands overlapped at
220 bp). This finding indicated that the SP-A1 gene can be
expressed in the renal tissues and HK-2 cells. We also used
another primer pair that is common to SP-A1 and SP-A2
(295 bp) to amplify the SP-A cDNA segments of the HK-2
cells and then performed direct sequencing. The sequen-
cing data, which were evaluated by the BLAST tool on
PUBMED, correspond to the expected sequences of SP-A1SP-A
1 2 3
33 kDa
Figure 6 Western blot analysis of human renal and alveolar
tissues and cultured HK-2 cells developed using the surfactant
protein A (SP-A) polyclonal antibody. Immunoblot detection of
human renal tissues (Lane 2) and HK-2 cells (Lane 3) showed bands
at approximately 33 kDa. Alveolar tissues were used as positive
controls (Lane 1). The stained intensity bands of renal tissues and
HK-2 cells were decreased compared with those in the lungs.






Figure 7 Dose-dependent effects of lipopolysaccharide (LPS) on the expressions of surfactant protein-A (SP-A) mRNA and protein for
8 h. HK-2 cells were exposed to 0, 0.1, 1, 2, 5, and 10 μg/mL of LPS for 8 h. (A) Total RNA was prepared for RT-PCR analysis of SP-A mRNA
and for gel electrophoresis of SP-A1 and SP-A2 mRNA. (B) Comparison of SP-A1 and SP-A2 mRNA after exposure to different concentrations of
LPS for 8 h. (C) Comparison of the SP-A protein after exposure to different concentrations of LPS for 8 h. Each value represents the mean ±
SEM for n = 3. The symbol “a” indicates that the value significantly (P < 0.05) differed from the control group. M, 100 bp DNA marker.
Liu et al. Journal of Inflammation 2013, 10:2 Page 6 of 8
http://www.journal-inflammation.com/content/10/1/2and SP-A2. The primer pairs specific to SP-A1 or SP-A2
were also used to identify the expressions of the SP-A1 and
SP-A2 genes. Considering the result obtained from the
Apa I digestion experiment, we conclude that the SP-A1
and SP-A2 genes were expressed in the renal tissues and
HK-2 cells in the same way as in the alveolar type II cells.
However, the SP-A mRNA level was relatively reduced in
the renal tissues and HK-2 cells than in the lungs. We did
not determine whether the surface area of the urinary tract
is smaller, although the SP-A gene expression in the renal
tissue was found to be much lower, which may still be
enough to function in local host defence.
In the present study, we have shown that both SP-A1
and SP-A2 mRNA is expressed in renal tissue and theHK-2 cell line. As the SP-A protein can be detected by
the polyclonal antibody of SP-A as well in renal tissue
and the HK-2 cell line, as shown by western blotting and
immunohistochemistry, the polyclonal antibody could
potential recognise epitopes in both the SP-A1 and SP-
A2 proteins. Therefore, the localisation and synthesis of
SP-A occur in the kidneys. Immunostained SP-A is
present in the epithelial cells of different tissues, such as
in the Eustachian tube [12] and nasal cavities [27].
Immunoreactive SP-A is also found in human Eustachian
tube lavage [12] and middle ear fluids [27]. We fre-
quently detected that the renal tubular epithelial cells
contain the SP-A protein, which is in good agreement
with the findings of a previous study [21].Gram-negative






Figure 8 Time-dependent effects of lipopolysaccharide (LPS) on the expressions of surfactant protein-A (SP-A) mRNA and protein. HK-2
cells were exposed to 5 μg/mL of LPS for 0, 2, 4, 8, 16, and 24 h. (A) Gel electrophoresis of SP-A1 and SP-A2 mRNA. (B) Comparison of SP-A1 and
SP-A2 mRNA after exposure to 5 μg/mL of LPS at different time points. (C) Comparison of SP-A protein after exposure to 5 μg/mL of LPS at
different time points. Each value represents the mean ± SEM for n = 3. The symbol “a” indicates that the value significantly (P < 0.05) differed from
the control group. M, 100 bp DNA marker.
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of urinary tract infection. LPS is the major component
of E. coli. Thus, the severity and time course of kid-
ney inflammation may depend on the amount of LPS.
SP-A is the most abundant surfactant protein in the
lungs and contributes to lung host defence. A previ-
ous study reported that SP-A gene knocked-out mice
are susceptible to lung infection caused by several
pathogens. In the present study, the levels of SP-A1
and SP-A2 mRNA and protein in the HK-2 cells were
significantly increased after LPS treatment. This finding
indicated that SP-A may play an anti-inflammatory role
in kidney infection.In summary, the following conclusions are presented.
First, human renal tubular epithelial cells can transcribe
both SP-A1 and SP-A2 genes. Second, LPS induces
SP-A1 and SP-A2 mRNA and protein syntheses in
time- and dose-dependent manners. Third, SP-A in
the renal tissues may prevent the spread of specific
infections from the urinary tract to other body parts.
However, the mechanism should be further studied.Conclusion
In summary, human renal tubular epithelial cells can ex-
press both SP-A1 and SP-A2 genes, which may play
Liu et al. Journal of Inflammation 2013, 10:2 Page 8 of 8
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kidney.
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